Qc Pink Bismuth
NDC Package 63868-421-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Qc Pink Bismuth is ▪chew completely or dissolve tablets in mouth.▪adults and children 12 years and older: 2 tablets (1 dose) every ½ hour to 1 hour as needed▪do not exceed 8 doses (16 tablets) in 24 hours▪use until diarrhea stops but not more than 2 days▪children under 12 years: ask a doctor▪drink plenty clear fluids to help prevent dehydration caused by diarrhea. Marketed by Chain Drug Marketing Association, this product is identified by NDC 63868-421 and is authorized under FDA application part335.

Identification & Billing

NDC Package Code
63868-421-30
Package Description
5 BLISTER PACK in 1 CARTON / 6 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
63868-421
11-Digit Billing Format
63868042130
RxNorm Crosswalk
RxCUI: 308761 - bismuth subsalicylate 262 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Qc Pink Bismuth Stomach Relief
Dosage Form
-
Usage Information
▪chew completely or dissolve tablets in mouth.▪adults and children 12 years and older: 2 tablets (1 dose) every ½ hour to 1 hour as needed▪do not exceed 8 doses (16 tablets) in 24 hours▪use until diarrhea stops but not more than 2 days▪children under 12 years: ask a doctor▪drink plenty clear fluids to help prevent dehydration caused by diarrhea.

Regulatory & Marketing

Labeler Name
Chain Drug Marketing Association
FDA Application #
part335
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-24-2020
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63868-421-30 identifies a specific commercial package of 5 blister pack in 1 carton / 6 tablet, chewable in 1 blister pack of Qc Pink Bismuth Stomach Relief, labeled by Chain Drug Marketing Association. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Marketing Association on February 24, 2020. The current certification is valid through December 31, 2021.

How is this Chain Drug Marketing Association product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868042130. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63868-421-30
11-Digit CMS (5-4-2)
63868-0421-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.